WHO 2008 mature T-cell and NK-cell neoplasms
Mature T-cell and NK-cell neoplasms . | Incidence (%)* . |
---|---|
T-cell prolymphocytic leukemia | |
T-cell large granular lymphocytic leukemia | |
Chronic lymphoproliferative disorder of NK cells† | |
Aggressive NK-cell leukemia | |
Systemic EBV-positive T-cell lymphoproliferative disease of childhood | |
Hydroa vacciniforme-like lymphoma | |
Adult T-cell leukemia/lymphoma | 9.6 |
Extranodal NK/T-cell lymphoma, nasal type | 10.4 |
Enteropathy-associated T-cell lymphoma | 4.7 |
Hepatosplenic T-cell lymphoma | |
Subcutaneous panniculitis-like T-cell lymphoma | 0.9 |
Mycosis fungoides | |
Sézary syndrome | |
Primary cutaneous CD30+ T-cell lymphoproliferative disorders | |
Lymphomatoid papulosis | |
Primary cutaneous anaplastic large cell lymphoma | 1.7 |
Primary cutaneous γδ T-cell lymphoma | |
Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma† | |
Primary cutaneous CD4+ small/medium T-cell lymphoma† | |
Peripheral T-cell lymphoma, NOS | 25.6 |
Angioimmunoblastic T-cell lymphoma | 19.5 |
Anaplastic large cell lymphoma, ALK-positive | 6.6 |
Anaplastic large cell lymphoma, ALK-negative† | 5.5 |
Mature T-cell and NK-cell neoplasms . | Incidence (%)* . |
---|---|
T-cell prolymphocytic leukemia | |
T-cell large granular lymphocytic leukemia | |
Chronic lymphoproliferative disorder of NK cells† | |
Aggressive NK-cell leukemia | |
Systemic EBV-positive T-cell lymphoproliferative disease of childhood | |
Hydroa vacciniforme-like lymphoma | |
Adult T-cell leukemia/lymphoma | 9.6 |
Extranodal NK/T-cell lymphoma, nasal type | 10.4 |
Enteropathy-associated T-cell lymphoma | 4.7 |
Hepatosplenic T-cell lymphoma | |
Subcutaneous panniculitis-like T-cell lymphoma | 0.9 |
Mycosis fungoides | |
Sézary syndrome | |
Primary cutaneous CD30+ T-cell lymphoproliferative disorders | |
Lymphomatoid papulosis | |
Primary cutaneous anaplastic large cell lymphoma | 1.7 |
Primary cutaneous γδ T-cell lymphoma | |
Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma† | |
Primary cutaneous CD4+ small/medium T-cell lymphoma† | |
Peripheral T-cell lymphoma, NOS | 25.6 |
Angioimmunoblastic T-cell lymphoma | 19.5 |
Anaplastic large cell lymphoma, ALK-positive | 6.6 |
Anaplastic large cell lymphoma, ALK-negative† | 5.5 |